Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

BioPlus Acquisition (BIOS)

BioPlus Acquisition Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:BIOS
DateTimeSourceHeadlineSymbolCompany
04/10/202312:30GlobeNewswire Inc.BioPlus Acquisition Corp. Announces Termination of Business Combination Agreement with Avertix Medical, Inc. and its Intention to LiquidateNASDAQ:BIOSBioPlus Acquisition Corporation
04/10/202312:30GlobeNewswire Inc.Avertix and BIOS Acquisition Corporation Mutually Agree to Terminate Proposed Business CombinationNASDAQ:BIOSBioPlus Acquisition Corporation
16/08/202313:30GlobeNewswire Inc.Heart & Rhythm Institute of Trinity and Avertix Announce Partnership to Improve Cardiac Care and Patient MonitoringNASDAQ:BIOSBioPlus Acquisition Corporation
17/07/202313:00GlobeNewswire Inc.Renown Cardiologist and Professor Ian T. Meredith, MD to Join Avertix Medical’s Board of DirectorsNASDAQ:BIOSBioPlus Acquisition Corporation
14/06/202311:09Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:BIOSBioPlus Acquisition Corporation
14/06/202311:06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BIOSBioPlus Acquisition Corporation
13/06/202313:30GlobeNewswire Inc.Avertix’s Guardian™ System, First and Only FDA-Approved Implantable Heart Attack Detection and Warning System, Now Available at AdventHealth OrlandoNASDAQ:BIOSBioPlus Acquisition Corporation
30/05/202321:04Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:BIOSBioPlus Acquisition Corporation
19/05/202321:50Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:BIOSBioPlus Acquisition Corporation
19/05/202321:05Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:BIOSBioPlus Acquisition Corporation
15/05/202321:29Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:BIOSBioPlus Acquisition Corporation
15/05/202311:38Edgar (US Regulatory)Securities Registration: Business Combination (s-4)NASDAQ:BIOSBioPlus Acquisition Corporation
12/05/202321:17Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:BIOSBioPlus Acquisition Corporation
03/05/202313:47Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:BIOSBioPlus Acquisition Corporation
03/05/202313:44Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BIOSBioPlus Acquisition Corporation
03/05/202313:30GlobeNewswire Inc.Avertix, Maker of First and Only FDA-Approved Implantable Heart Attack Warning System, to Become Publicly Traded via Merger with BIOS Acquisition CorporationNASDAQ:BIOSBioPlus Acquisition Corporation
27/04/202321:35Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:BIOSBioPlus Acquisition Corporation
14/02/202320:39Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:BIOSBioPlus Acquisition Corporation
02/02/202315:10Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:BIOSBioPlus Acquisition Corporation
03/11/202221:10Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:BIOSBioPlus Acquisition Corporation
11/10/202221:07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BIOSBioPlus Acquisition Corporation
10/08/202221:33Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:BIOSBioPlus Acquisition Corporation
12/05/202221:55Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:BIOSBioPlus Acquisition Corporation
11/03/202221:05Edgar (US Regulatory)Annual Report (10-k)NASDAQ:BIOSBioPlus Acquisition Corporation
09/02/202219:14Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:BIOSBioPlus Acquisition Corporation
06/12/202113:00GlobeNewswire Inc.BioPlus Acquisition Corp. Announces Pricing of Upsized $200,000,000 Initial Public OfferingNASDAQ:BIOSBioPlus Acquisition Corporation
03/12/202101:55GlobeNewswire Inc.BioPlus Acquisition Corp. Announces Pricing of Upsized $200,000,000 Initial Public OfferingNASDAQ:BIOSBioPlus Acquisition Corporation
03/02/202013:30GlobeNewswire Inc.Option Care Health Completes Reverse Stock Split and Ticker Symbol ChangeNASDAQ:BIOSBioPlus Acquisition Corporation
26/12/201921:24GlobeNewswire Inc.RLH Corporation Appoints R. Carter Pate as ChairmanNASDAQ:BIOSBioPlus Acquisition Corporation
18/12/201914:22GlobeNewswire Inc.Option Care Health to Participate in the 38th Annual J.P. Morgan Healthcare ConferenceNASDAQ:BIOSBioPlus Acquisition Corporation
 Showing the most relevant articles for your search:NASDAQ:BIOS